Option delistings effective March 24th include Aligos Therapeutics (ALGS), Allbirds (BIRD), Biotricity Inc (BTCY), DWTX Stock (DWTX), Dixie Group Inc (DXYN), Genetic Technologies Limited (ADR) (GENE), Galecto (GLTO), ESS Tech (GWH), Trevena Inc (TRVN), and iShares S&P Develpd ex US Prprty Indx Fd (WPS).
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGS:
- Aligos Therapeutics announces inducement grants under Nasdaq listing rule
- Biotech Alert: Searches spiking for these stocks today
- Aligos Therapeutics Faces Challenges in Developing Hepatitis B Treatments Amidst Industry Competition
- Aligos Therapeutics price target lowered to $70 from $75 at H.C. Wainwright
- Aligos Therapeutics Advances Pipeline Amid Financial Challenges